# Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

> **NCT02601040** · PHASE4 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 13500 (actual)

## Conditions studied

- Hepatitis A

## Interventions

- **BIOLOGICAL:** Attenuated Hepatitis A Vaccine, H2 Strain
- **BIOLOGICAL:** Inactivated Hepatitis A Vaccine, Lu8 Strain
- **BIOLOGICAL:** Group A Meningococcal Polysaccharide vaccine

## Key facts

- **NCT ID:** NCT02601040
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-06
- **Final completion:** 2015-10
- **Target enrollment:** 13500 (ACTUAL)
- **Last updated:** 2015-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02601040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02601040, "Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02601040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*